The Basser Center has launched the Men & BRCA program to accelerate research and provide men with specialized BRCA-related care. Dr. Kara Maxwell, Director of the new program, says that it is “part of a three-pronged approach comprising education, clinical care, and research.”

Jacquelyn Powers, MS, LCGC, a genetic counselor at the Basser Center, shares information about genetic counseling and testing services available at the Penn Medicine Mariann and Robert MacDonald Cancer Risk Evaluation Program and at the Basser Center.

Ovarian cancer is known as the silent killer, and Christine Hussey and her mother, Betty Walter, who have both participated in genetic testing at the Basser Center, know the importance of early detection.

A study conducted at Penn Medicine’s Abramson Cancer Center has revealed possible drivers of recurrence in breast and ovarian tumors with BRCA1/BRCA2 mutations. Senior study author Katherine Nathanson, MD, the Pearl Basser Professor for BRCA-Related Research and deputy director of the Abramson Cancer Center, discussed the study results and what they might reveal about the mechanisms of cancer recurrence.

Trudy Orthey learned she had a BRCA2 gene mutation after a family member’s cancer diagnosis. Now as a Basser Center patient, Trudy is cancer free and shares her journey with ovarian cancer.

Grammy Award-winning artist, songwriter, and actress Sara Bareilles performed at the Basser Center's fourth Basser Jean Bash last week in New York City. The sold-out event raised nearly $17 million to help find a cure for BRCA-related cancers.

Sara Bareilles shows off her smile while attending the 4th Annual Basser Jean Bash held at The Glasshouse in N.Y.C. on Nov. 15, 2022.

The Basser Center held its Basser Jean Bash on November 15th in Manhattan where all attendees wore their most stylish denim. The event it was an event about your "genes" that helped to raise money to find a cure for BRCA-related cancers.

The Basser Center research team worked to address outstanding questions about cancer recurrence in BRCA1/2 mutation carriers by performing an analysis of paired primary and recurrent BRCA1/2 mutation-associated tumors.

Susan Domchek, MD discusses the significance of genetics, genetic testing, the risk of developing cancer with a BRCA gene mutation and more.

Dr. Susan Domchek, executive director of the Basser Center, is interviewed with her patient, Karen, on what leading a vaccine trial to prevent breast cancer can really mean for patients and their families.

Robert Vonderheide, MD, PhD, director of the Abramson Cancer Center, and Susan Domchek, MD, executive director of the Basser Center for BRCA, are interviewed on the new Basser Cancer Interception Institute’s efforts studying a vaccine to reduce cancer risk among individuals who carry BRCA1/2 mutations by recognizing and killing cancer cells “before anyone even knew they were there.”

Penn alumni Mindy and Jon Gray have gifted $55 million to the University of Pennsylvania’s Basser Center at the Abramson Cancer Center to establish the Basser Cancer Interception Institute, which aims to target the early stages of hereditary cancers.